Physician profile
William Gil Davis
NPI 1063482453
$1,972.03
in general payments reported to CMS, 2019-2025
16 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $75.31 · 2021: $53.11 · 2022: $379 · 2023: $261 · 2024: $515 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990 · Entertainment: $36.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.69 |
| Entertainment | $36.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $367.46 | 2023-2025 | Acthar |
| Bausch & Lomb Americas INC. | $362.70 | 2024-2025 | Infuse, Vyzulta, Miebo |
| Alcon Vision LLC | $219.29 | 2019-2023 | Total30 |
| Maculogix, INC. | $167.26 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $163.84 | 2020-2023 | Acuvue |
| Glaukos Corporation | $139.14 | 2025 | Photrexa Viscous and Photrexa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $122.10 | 2019-2021 | |
| Coopervision INC. | $98.50 | 2022 | |
| Rxsight INC | $98.41 | 2022 | |
| Optos, INC. | $67.62 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $65.96 | 2019 | |
| Lombart Brothers, INC. | $30.26 | 2019 | |
| Dompe US, INC. | $24.11 | 2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $19.06 | 2019 | |
| Quidel Corporation | $13.97 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.